bioRxiv Science⌕ Search

Biology subjects

Butchy, A. A.

Publications and source records attributed to Butchy, A. A..

2 recordsLinked to original sources

Computational modeling of cell signaling and mutations in pancreatic cancer

Published research articles are rich sources of data when the knowledge is incorporated into models. Complex biological systems benefit from computational modelings ability to elucidate dynamics, explain data and address hypotheses. Modeling of pancreatic cancer could guide treatment of this devastating disease that has a known mutational profile disrupting signaling pathways but no reliable therapies. The approach described here is to utilize discrete modeling of the major signaling pathways, metabolism and the tumor microenvironment including macrophages. This modeling approach allows for abstraction in order to assemble large networks to capture numerous facets of the biological system under investigation. The Hallmarks of Cancer are represented as the processes of apoptosis, autophagy, cell cycle progression, inflammation, immune response, oxidative phosphorylation and proliferation. The model is initialized with pancreatic cancer receptors and mutations and simulated in time. The model portrays the hallmarks of cancer and suggests combinations of inhibitors as therapies.

systems biology↗

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting

Chimeric antigen receptors (CARs) and synthetic Notch (synNotch) receptors are engineered cell-surface receptors that sense a target antigen and respond by activating T cell receptor signaling or a customized gene program, respectively. To expand the targeting capabilities of these receptors, we have developed switchable adaptor receptor systems for which receptor specificity can be directed post-translationally via covalent attachment of a co-administered antibody. Instead of directly targeting an antigen, our receptors contain the SNAPtag self-labeling enzyme, which reacts with benzylguanine (BG)-conjugated antibodies to assemble covalently-associated antigen receptors. We demonstrate that activation of SNAP-CAR and SNAP-synNotch receptors and their downstream effector functions can be successfully targeted by several clinically-relevant BG-conjugated antibodies in an antigen-specific and antibody dose-dependent manner. To better define parameters affecting receptor signaling, we developed a mathematical model of switchable receptor systems. SNAP receptors provide a powerful new strategy to post-translationally reprogram the targeting specificity of engineered cells.

synthetic biology↗